U.S. Small Molecule Innovator CDMO Market (2025 - 2033) Size, Share & Trends Analysis Report By Product (Small Molecule API, Small Molecule Drug Product), By Stage Type, By Therapeutic Area, By Customer Type, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation and Scope
                    1.2. Market Definitions
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Value chain based analysis (Model 2)
                        1.7.3. Multivariate Analysis (Model 3)
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. U.S. Small Molecule Innovator CDMO Market: Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market Outlook
                        3.1.2. Ancillary Market Outlook
                    3.2. U.S. Small Molecule Innovator CDMO Market Dynamics
                        3.2.1. Market Driver Impact Analysis
                        3.2.2. Market Restraint Analysis
                    3.3. Technological Landscape
                    3.4. Pricing Model Analysis
                    3.5. U.S. Small Molecule Innovator CDMO Market: Analysis Tools
                        3.5.1. Porter’s Five Forces Analysis
                        3.5.2. PESTEL Analysis
Chapter 4. U.S. Small Molecule Innovator CDMO Market: Product Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. U.S. Small Molecule Innovator CDMO Market Product Movement Analysis
                    4.3. U.S. Small Molecule Innovator CDMO Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
                    4.4. Small Molecule API
                        4.4.1. Small Molecule API Market Estimates and Forecasts, 2021 - 2033 (USD million)
                    4.5. Small Molecule Drug Product
                        4.5.1. Small Molecule Drug Product Market Estimates and Forecasts, 2021 - 2033 (USD million)
                        4.5.2. Oral Solid Dose
                            4.5.2.1. Oral Solid Dose Market Estimates and Forecasts, 2021 - 2033 (USD million)
                        4.5.3. Semi-Solid Dose
                            4.5.3.1. Semi-Solid Dose Market Estimates and Forecasts, 2021 - 2033 (USD million)
                        4.5.4. Liquid Dose
                            4.5.4.1. Liquid Dose Market Estimates and Forecasts, 2021 - 2033 (USD million)
                        4.5.5. Others
                            4.5.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD million)
Chapter 5. U.S. Small Molecule Innovator CDMO Market: Stage Type Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. U.S. Small Molecule Innovator CDMO Market Stage Type Movement Analysis
                    5.3. U.S. Small Molecule Innovator CDMO Market Size & Trend Analysis, by Stage Type, 2021 to 2033 (USD Million)
                    5.4. Preclinical
                        5.4.1. Preclinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    5.5. Clinical
                        5.5.1. Clinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        5.5.2. Phase I
                            5.5.2.1. Phase I Market Estimates and Forecasts, 2021 - 2033 (USD million)
                            5.5.2.2. Small
                                5.5.2.2.1. Small Market Estimates and Forecasts, 2021 - 2033 (USD million)
                            5.5.2.3. Medium
                                5.5.2.3.1. Medium Market Estimates and Forecasts, 2021 - 2033 (USD million)
                            5.5.2.4. Large
                                5.5.2.4.1. Large Market Estimates and Forecasts, 2021 - 2033 (USD million)
                        5.5.3. Phase II
                            5.5.3.1. Phase II Market Estimates and Forecasts, 2021 - 2033 (USD million)
                            5.5.3.2. Small
                                5.5.3.2.1. Small Market Estimates and Forecasts, 2021 - 2033 (USD million)
                            5.5.3.3. Medium
                                5.5.3.3.1. Medium Market Estimates and Forecasts, 2021 - 2033 (USD million)
                            5.5.3.4. Large
                                5.5.3.4.1. Large Market Estimates and Forecasts, 2021 - 2033 (USD million)
                        5.5.4. Phase III
                            5.5.4.1. Phase III Market Estimates and Forecasts, 2021 - 2033 (USD million)
                            5.5.4.2. Small
                                5.5.4.2.1. Small Market Estimates and Forecasts, 2021 - 2033 (USD million)
                            5.5.4.3. Medium
                                5.5.4.3.1. Medium Market Estimates and Forecasts, 2021 - 2033 (USD million)
                            5.5.4.4. Large
                                5.5.4.4.1. Large Market Estimates and Forecasts, 2021 - 2033 (USD million)
                    5.6. Commercial
                        5.6.1. Commercial Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. U.S. Small Molecule Innovator CDMO Market: Customer Type Estimates & Trend Analysis
                    6.1. Segment Dashboard
                    6.2. U.S. Small Molecule Innovator CDMO Market Customer Type Movement Analysis
                    6.3. U.S. Small Molecule Innovator CDMO Market Size & Trend Analysis, by Customer Type, 2021 to 2033 (USD Million)
                    6.4. Pharmaceutical
                        6.4.1. Pharmaceutical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.4.2. Small
                            6.4.2.1. Small Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.4.3. Medium
                            6.4.3.1. Medium Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                        6.4.4. Large
                            6.4.4.1. Large Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.5. Biotechnology
                        6.5.1. Biotechnology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. U.S. Small Molecule Innovator CDMO Market: Therapeutic Area Estimates & Trend Analysis
                    7.1. Segment Dashboard
                    7.2. U.S. Small Molecule Innovator CDMO Market Therapeutic Area Movement Analysis
                    7.3. U.S. Small Molecule Innovator CDMO Market Size & Trend Analysis, by Therapeutic Area, 2021 to 2033 (USD Million)
                    7.4. Cardiovascular diseases
                        7.4.1. Cardiovascular diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    7.5. Oncology
                        7.5.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    7.6. Respiratory disorders
                        7.6.1. Respiratory disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    7.7. Neurology
                        7.7.1. Neurology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    7.8. Metabolic Disorders
                        7.8.1. Metabolic Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    7.9. Infectious Diseases
                        7.9.1. Infectious Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                    7.10. Others
                        7.10.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
                    8.1. Company Categorization
                    8.2. U.S. Small Molecule Innovator CDMO Market Share Analysis, 2024
                    8.3. Company Profiles
                        8.3.1. Piramal Pharma Solutions
                            8.3.1.1. Company overview
                            8.3.1.2. Financial performance
                            8.3.1.3. Product benchmarking
                            8.3.1.4. Strategic initiatives
                        8.3.2. CordenPharma International
                            8.3.2.1. Company overview
                            8.3.2.2. Financial performance
                            8.3.2.3. Product benchmarking
                            8.3.2.4. Strategic initiatives
                        8.3.3. Wuxi AppTec
                            8.3.3.1. Company overview
                            8.3.3.2. Financial performance
                            8.3.3.3. Product benchmarking
                            8.3.3.4. Strategic initiatives
                        8.3.4. Cambrex Corporation
                            8.3.4.1. Company overview
                            8.3.4.2. Financial performance
                            8.3.4.3. Product benchmarking
                            8.3.4.4. Strategic initiatives
                        8.3.5. Recipharm AB
                            8.3.5.1. Company overview
                            8.3.5.2. Financial performance
                            8.3.5.3. Product benchmarking
                            8.3.5.4. Strategic initiatives
                        8.3.6. Thermo Fisher Scientific, Inc.
                            8.3.6.1. Company overview
                            8.3.6.2. Financial performance
                            8.3.6.3. Product benchmarking
                            8.3.6.4. Strategic initiatives
                        8.3.7. Lonza
                            8.3.7.1. Company overview
                            8.3.7.2. Financial performance
                            8.3.7.3. Product benchmarking
                            8.3.7.4. Strategic initiatives
                        8.3.8. Catalent Inc.
                            8.3.8.1. Company overview
                            8.3.8.2. Financial performance
                            8.3.8.3. Product benchmarking
                            8.3.8.4. Strategic initiatives
                        8.3.9. Siegfried Holding AG
                            8.3.9.1. Company overview
                            8.3.9.2. Financial performance
                            8.3.9.3. Product benchmarking
                            8.3.9.4. Strategic initiatives
                        8.3.10. Boehringer Ingelheim
                            8.3.10.1. Company overview
                            8.3.10.2. Financial performance
                            8.3.10.3. Product benchmarking
                            8.3.10.4. Strategic initiatives
                        8.3.11. Labcorp
                            8.3.11.1. Company overview
                            8.3.11.2. Financial performance
                            8.3.11.3. Product benchmarking
                            8.3.11.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 U.S. Small Molecule Innovator CDMO market, by product, 2021 - 2033 (USD Million)
Table 3 U.S. Small Molecule Innovator CDMO market, by stage type, 2021 - 2033 (USD Million)
Table 4 U.S. Small Molecule Innovator CDMO market, by customer type, 2021 - 2033 (USD Million)
Table 5 U.S. Small Molecule Innovator CDMO market, by therapeutic area, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 U.S. Small Molecule Innovator CDMO market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Market formulation & validation
Fig. 7 Commodity flow analysis
Fig. 8 Value-Chain-Based Sizing & Forecasting
Fig. 9 QFD model sizing & forecasting
Fig. 10 Bottom-up approach
Fig. 11 Market snapshot
Fig. 12 Segment snapshot
Fig. 13 Segment snapshot
Fig. 14 Segment snapshot
Fig. 15 Competitive landscape snapshot
Fig. 16 Parent market outlook, 2024 (USD Million)
Fig. 17 Ancillary market outlook, 2024 (USD Million)
Fig. 18 U.S. Small Molecule Innovator CDMO market dynamics
Fig. 19 Porter’s five forces analysis
Fig. 20 PESTEL analysis
Fig. 21 U.S. Small Molecule Innovator CDMO market Product outlook: Segment dashboard
Fig. 22 U.S. Small Molecule Innovator CDMO market, by Product segment: Market share, 2024 & 2033
Fig. 23 Small Molecule API market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 24 Small Molecule Drug Product market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 25 Oral Solid Dose market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 26 Semi-Solid Dose market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 27 Liquid Dose market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 28 Others market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 29 U.S. Small Molecule Innovator CDMO market Stage Type outlook: Segment dashboard
Fig. 30 Small Molecule Innovator CDMO market, by Stage Type segment: Market share, 2024 & 2033
Fig. 31 Preclinical market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 32 Clinical market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 33 Phase I market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 34 Phase II market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 35 Phase III market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 36 U.S. Small Molecule Innovator CDMO market Customer Type outlook: Segment dashboard
Fig. 37 Small Molecule Innovator CDMO market, by Customer Type segment: Market share, 2024 & 2033
Fig. 38 Pharmaceutical market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 39 Biotechnology market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 40 U.S. Small Molecule Innovator CDMO market Therapeutic Area outlook: Segment dashboard
Fig. 41 Small Molecule Innovator CDMO market, by Therapeutic Area segment: Market share, 2024 & 2033
Fig. 42 Cardiovascular diseases market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 43 Oncology market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 44 Respiratory disorders market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 45 Neurology market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 46 Metabolic Disorders market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 47 Infectious Diseases market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 48 Others market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 49 Market participant categorization
Fig. 50 Heat map analysis